Ecolab Inc. vs Freeport-McMoRan, Inc. — Stock Comparison
Q·Score Breakdown
6.8
Hold
Overall
8.4
Buy
Quality
Health
Growth
Valuation
Sentiment
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
Analyst Consensus
BUY
Target $317.48 (+21.7%)
21 analysts
BUY
Target $67.90 (+18.1%)
21 analysts
Fundamentals
ECL
FCX
35.8×
Trailing P/E
30.4×
27.2×
Forward P/E
15.5×
12.8%
Profit Margin
10.3%
44.4%
Gross Margin
37.1%
22.4%
ROE
15.6%
10.0%
Revenue Growth
8.8%
7.8%
Earnings Growth
154.0%
1.02
Beta
1.47
—
Price / Book
—
$73.7B
Market Cap
$82.5B
$249 – $309
52-Week Range
$35 – $71
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.